Clinical experience with enteral tube nutrition and Nutrison® range of enteral tubes in patients with specific enteral feeding requirements in Spain: The NUTRECONSONDA study

Enteral nutrition (EN) is a critical medical nutritional treatment designed to meet the specific micro- and macronutrient requirements of patients unable to achieve adequate nutrition through oral intake. The aim of this study is to review the use of EN by tube in routine clinical practice, focusing on its management in patients with specific nutritional requirements, and to evaluate the effectiveness, tolerability, and quality of life improvements associated with the Nutrison® range of enteral tube enteral formulas. NUTRECONSONDA was a nationwide, multicentre, cross-sectional ecological study. Aggregated data were collected from the experience and knowledge of 142 physicians with experience treating patients with EN through an online survey. According to the physicians, the main indications to EN were neoplasms (43.3 %) and neuromotor disorders (36.4 %), the most common administration techniques were percutaneous endoscopic gastrostomy tube (35.6 %) and nasogastric tube (29.2 %), the most common type of feeding was bolus feeding (52.1 %), and most frequent symptoms were diarrhoea (29.2 %), nausea (21.7 %), regurgitation (21.4 %) and abdominal distension (21.1 %). Moreover, 82.8 % of patients reported good tolerance to enteral formulas and these were effective in 91.4 % of patients in terms of nutritional requirements. The most important criteria considered for the selection of an enteral formula of the Nutrison® range in patients with specific EN requirements were patient's energy and nutritional needs (score: 8.8), nutritional formula composition (score: 8.5) and tolerability of the formula (score: 8.3). Nutrison® enteral formulas were effective in terms of nutritional requirements in 92.5 % of patients, had good tolerability in 86.9 %, improved quality of life in 67.1 % and improved general health status in 75.1 %. Most patients were also satisfied with Nutrison® enteral formulas (87.2 %) and their delivery system (87.5 %). Furthermore, the most representative lipid profile benefits in patients treated with Nutrison® enteral formulas were a higher EPA and DHA intake (54.9 %) and a higher combination of medium chain triglycerides (45.5 %). The key factors influencing formula selection were patient energy requirements, formula composition, and tolerance. Enteral formulas of the Nutrison® range were effective, safe and improved quality of life and lipid profile in most of the patients with specific nutritional requirements.

Authors

Institutions

Publication Details

Journal
Clinical Nutrition Open Science
Published
2025-02-16
DOI
https://doi.org/10.1016/j.nutos.2025.02.007
Primary Topic
Clinical Nutrition and Gastroenterology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical experience with enteral tube nutrition and Nutrison® range of enteral tubes in patients with specific enteral feeding requirements in Spain: The NUTRECONSONDA study

Irene Gonzalo Montesinos, Rosa de Diego Martínez, María Alonso Casasús, Yaiza Lopez Plasencia et al.
Clinical Nutrition Open Science
Clinical Nutrition and Gastroenterology
article

Clinical experience with enteral tube nutrition and Nutrison® range of enteral tubes in patients with specific enteral feeding requirements in Spain: The NUTRECONSONDA study

Irene Gonzalo Montesinos, Rosa de Diego Martínez, María Alonso Casasús, Yaiza Lopez Plasencia, V. Martínez Vaello, Juana María Rabat Restrepo, José Pablo Suárez Llanos, Ana Jiménez Portilla, Rocío Campos del Portillo, Rafael Castillo Rubio, Maria Araceli Garcia Núñez, Nelia Hernández, Juan Manuel Guardia Baena, Luna Florencio Ojeda, Beatriz Lardiés Sánchez, Eduardo Platero Rodrigo, Diana Ariadel Cobo, M. Ventosa Viña, Cristina Lorenzo González, Ana Artero Fullana, C. Díaz, Marco Villa, Laura Calles Romero, Mercedes García, Antonio Jesús Martínez-Ortega, Antonio Valero, Maria Macarena Moreno Martinez, Cristina Aguilera, María José Pena López, Christian Salom Vendrell, Elena Márquez Mesa, Alexander Martínez, Juan Camilo Ochoa, Elena Abad, A. Bayona Cebada, María Laínez López, Irene Navarro, Miguel Antonio Sampedro Núñez, Victoria Luna López, Tomás Martín Folgueras, Lorena Suárez Gutiérrez, Juan Manuel Guardia-Baena, Francisco Javier Gómez Alfonso, Ana Hernández Moreno, Carlos E. Muñiz, Alfredo Molina, Joaquín Escribano, María Berrio Miranda, Laura Mola Reyes, Estefanía Santos Mazo, L Leunda Eizmendi, Patricia Díaz Guardiola, Arturo Lisbona Catalán, María Riestra Fernández, Salvador Benlloch, Nian Xiong, María D. Ballesteros‐Pomar, Beatriz González Aguilera, Pablo Carbo, Montserrat Gonzalo Marín, Cecilia Itzel Noriega Vega, Pau Peláez, Helena Requejo Salinas, Clara Marcuello, Sara Jiménez Blanco, Araceli Muñoz‐Garach, Beatriz Ugalde Abiega, Katherine García Malpartida, José Luis Lugo Arias, Silvia Veses Martín, Elena Carrillo Lozano, Ana Urioste Fondo, Belén Vega‐Piñero, Teresa García, Laura Ramos, Nataly Gardenia Ortega Romero, Dolores del Olmo, Elena González Arnáiz, Ángel Luis Abad-González, Daniel Antonio de Luis, María Maíz Jiménez, Olga Sánchez-Vilar, Naiara Modroño Móstoles, María José Molina Puerta, Eduardo Milton Ramos-Sanchez, Javier Jiménez, J Rodríguez, Ceferino Martínez‐Faedo, Soraya Lanes Iglesias, Antonio José Blanco Orenes, Carmen Ripa Ciaurriz, María José Jiménez Jiménez, Jara Altemir Trallero, Marta Llorca, Lourdes García Blasco, Silvia Pérez, Mercedes Ferrer Gómez, Andrea Alcaraz, M. Fernández, Concepcion Muñoz Jimenez, V Barriales Alvarez, J.C. Padillo, Juan Bautista Molina Soria, Carmen Ballesta Sánchez, Sergio Fuentes Tudanca, Andrea Micó García, José Antonio Martínez, María José Hernández, Juan Jacobo Molina, Renata Fonseca Vianna Lopez, Miguel Camblor, María José Tapia Guerrero, Sandra Fernandes Lucas, Yaiza García Delgado, Fernando Calvo Gracia, F. Baró, Marco Antonio Peña Duque, Silvia Dosil Gallardo, Manuel Cayón Blanco, Marián Irazábal, Mercedes Vázquez Gutiérrez, Orvelindo Rodríguez Hernandez, César Gonzalvo Díaz, D. Martín Iglesias, Alejandro Sanz París, R Pérez, A. I. Zomeño Ros, María Victoria Hernández Jiménez, Virginia Esperanza Fernandez Ruiz, A. Cremades, Octavio Pérez Alonso, Margarita Diez Muñiz-Alique, María José López-Madrazo, Jj AlfaroMartínez, Felipe Alvarez Navia, Guilherme Carvalho Monterio, Pablo Flors Villaverde, Ángel Pedro Crisolino Pozas, Mara Alarcón Chulilla, Maria Angeles Valero Zany, Laura De La Maza, Pablo José Ferreira Ocampo, Maria Jesús Chinchetru
article en

Abstract

Enteral nutrition (EN) is a critical medical nutritional treatment designed to meet the specific micro- and macronutrient requirements of patients unable to achieve adequate nutrition through oral intake. The aim of this study is to review the use of EN by tube in routine clinical practice, focusing on its management in patients with specific nutritional requirements, and to evaluate the effectiveness, tolerability, and quality of life improvements associated with the Nutrison® range of enteral tube enteral formulas. NUTRECONSONDA was a nationwide, multicentre, cross-sectional ecological study. Aggregated data were collected from the experience and knowledge of 142 physicians with experience treating patients with EN through an online survey. According to the physicians, the main indications to EN were neoplasms (43.3 %) and neuromotor disorders (36.4 %), the most common administration techniques were percutaneous endoscopic gastrostomy tube (35.6 %) and nasogastric tube (29.2 %), the most common type of feeding was bolus feeding (52.1 %), and most frequent symptoms were diarrhoea (29.2 %), nausea (21.7 %), regurgitation (21.4 %) and abdominal distension (21.1 %). Moreover, 82.8 % of patients reported good tolerance to enteral formulas and these were effective in 91.4 % of patients in terms of nutritional requirements. The most important criteria considered for the selection of an enteral formula of the Nutrison® range in patients with specific EN requirements were patient's energy and nutritional needs (score: 8.8), nutritional formula composition (score: 8.5) and tolerability of the formula (score: 8.3). Nutrison® enteral formulas were effective in terms of nutritional requirements in 92.5 % of patients, had good tolerability in 86.9 %, improved quality of life in 67.1 % and improved general health status in 75.1 %. Most patients were also satisfied with Nutrison® enteral formulas (87.2 %) and their delivery system (87.5 %). Furthermore, the most representative lipid profile benefits in patients treated with Nutrison® enteral formulas were a higher EPA and DHA intake (54.9 %) and a higher combination of medium chain triglycerides (45.5 %). The key factors influencing formula selection were patient energy requirements, formula composition, and tolerance. Enteral formulas of the Nutrison® range were effective, safe and improved quality of life and lipid profile in most of the patients with specific nutritional requirements.

Clinical Nutrition Open ScienceVol. 60
Hospital Universitario Virgen de las Nieves (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Hospital Universitario De Cabueñes (ES), Complejo Hospitalario Universitario de Albacete (ES)
Zero hunger
Openalex Percentile: Top 97%
Clinical Nutrition and Gastroenterology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.